Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
Intranasal immunization with whole inactivated virus (WIV) is an important strategy used for influenza prevention and control. However, a powerful mucosal adjuvant is required to improve nasal vaccine efficacy. Riboflavin, as a food additive with the advantages of being safe and low-cost, widely exi...
Guardado en:
Autores principales: | Yinyan Yin, Jinyuan Wang, Xing Xu, Bangyue Zhou, Sujuan Chen, Tao Qin, Daxin Peng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ab62b96f71549739a25795c7544f865 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro
por: Wang C, et al.
Publicado: (2017) -
A Genome-Wide CRISPR/Cas9 Screen Reveals that Riboflavin Regulates Hydrogen Peroxide Entry into HAP1 Cells
por: Tamutenda Chidawanyika, et al.
Publicado: (2020) -
Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens
por: Cynthia Calzas, et al.
Publicado: (2021) -
Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs
por: Dhakal S, et al.
Publicado: (2018) -
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
por: John D. Clements, et al.
Publicado: (2018)